丹芎通脉颗粒治疗冠心病心绞痛的临床研究  

Clinical study on Danxiong Tongmai Granulation in Treating Patients with Angina Pectori Caused by Coronary Heart Disease

作　　者：姚鹏 赵丽霞 吕庆超[3] 

机构地区：[1]武警济南消防医院 [2]山东省医学高等专科学校药理教研室 [3]山东省中医院督灸科,山东济南250021

出　　处：《中外医疗》2011年第1期22-24,共3页China & Foreign Medical Treatment

摘　　要：目的对丹芎通脉颗粒治疗冠心病心绞痛的疗效及安全性作出评价。方法采用随机对照,治疗组(A组)171例口服丹芎通脉颗粒(每次2袋,2次/d),对照组(B组)75例给予参芍胶囊口服(每次4袋,2次/d)。4周后进行心绞痛、主要症状、心电图、总有效率及毒副作用评估。结果治疗组心绞痛总有效率96.49%,明显优于对照组77.34%(P<0.01);治疗组心电图总有效率73.10%,明显优于对照组48.00%(P<0.01);治疗组对轻、中、较重度患者均有很好疗效。结论丹芎通脉颗粒治疗冠心病心绞痛疗效确切,无毒副作用。Objective To observe the effects of Danxiong Tongmai granulation（DTG） in treating angina pectoris caused by coronary heart diseadse（CHD） and eraluate its safety.Methods Randomized single-blind controlled design were adopted.One hundred and seventy one patients were treated with DTG（2 bags/1 times,2 times daily） and seventy-five patients in the control group done with shenshao capsule（SSC 4 capsules,2 times daily）.After four weeks of treatment,the data of angina pectoris,main symptoms,ECG,total effects were collected and evaluated.Results DTG appeared to be more effective than SSC for patients with mild,moderate,severe angina pectoris（P0.01）,except with mild stomach discomfort for a few patients,DTG has no side effects and toxicity.Conclusion DTG is an effective drug in treating angina pectoris and has no side effects and toxicity.

关 键 词：丹芎通脉颗粒 胸痹 冠心病 

分 类 号：R972[医药卫生—药品]